3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
12
Terminated
3
Unknown
2
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
697
Breast
53
Gastrointestinal
52
Thoracic
31
Gynecologic
26
Head & Neck
19
Dermatologic
10
Sarcoma
8
Other
6
Lymphoid
6
Endocrine
5
CNS
5
Other hematologic neoplasm
4
Plasma cell
2
Classical hematology
2
Other solid neoplasm
1
NET
1
Myeloid
1
Conditions
Neoplasms
23
Venous Thromboembolism
20
Febrile Neutropenia
20
Anemia
20
Thrombocytopenia
15
Myelodysplastic Syndromes
14
Leukemia, Myeloid, Acute
14
Lymphoma
12
Leukemia
12
Anemia, Refractory, with Excess of Blasts
10
Anemia, Aplastic
10
Colorectal Neoplasms
9
Breast Neoplasms
8
Anemia, Iron-Deficiency
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Anemia, Sickle Cell
7
Neutropenia
6
Multiple Myeloma
6
Ovarian Neoplasms
5
Neoplasms, Plasma Cell
5
Lymphoma, Follicular
5
Hematologic Neoplasms
5
Fanconi Anemia, Complementation Group D1
5
Hemophilia A
4
Chemotherapy-induced Thrombocytopenia
4
Stroke
3
Pulmonary Disease, Chronic Obstructive
3
Parkinson Disease
3
Osteoporosis
3
Multiple Sclerosis
3
Interventions
Goserelin
1
Estradiol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Prostatic Neoplasms
×
Classical hematology
×
Clear all
NCT05154474
2022-05-03
SPACE2
Weprom
Unknown
150 enrolled
NCT00303784
2020-11-27
PATCH
University College, London
Phase 3
Unknown
2,200 enrolled